Stalled initiatives to cut drug prices frustrate Trump

Wall Street Journal

21 February 2020 - President seeks a signature accomplishment on the high-profile issue, as polling shows unfavorable public opinion.

President Trump is campaigning for re-election in 2020 by saying he has made great progress in reducing drug prices. 

But the issue has been a source of frustration for him recently, according to people familiar with the matter, as polling shows a majority of Americans disapprove of his handling of the issue and Democratic challengers for the White House focus on how his initiatives have stalled.

Read Wall Street Journal article 

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing